BioNTech SE and Pfizer (PFE) recently received a positive recommendation from the European Medicines Agency for marketing ...

Pfizer is cutting costs, growing its core business, and trading at a deep discount despite looming patent losses and COVID ...

Pfizer Inc. (NYSE: PFE) announced today the completion of a global, ex-China, licensing agreement with 3SBio, Inc. (01530.HK) ...

The appointment of a seasoned pharmaceutical executive, George Tidmarsh, to run the FDA’s drug center underscores the ...

A Texas man is suing a California doctor for allegedly providing his girlfriend with abortion medication. The lawsuit—a civil ...

Pfizer (PFE) is currently under significant scrutiny due to a study linking its product, Depo-Provera, to increased health risks, and an associated Multi-District Litigation could have influenced its ...

Arizona Congressman Paul Gosar is reintroducing legislation that will let people sue vaccine makers if they believe a vaccine ...

The Business Research Company The Business Research Company's Vitamin And Dietary Supplement Global Market Report 2025 – Market Size, Trend ...

The rising occurrence of dysmenorrhea, along with greater awareness and advancements in diagnosis, is driving substantial growth in the dysmenorrhea ...

The Canadian Patent Office has a procedure for the “re-examination” of a granted patent. However, this procedure is rarely used in Canada for several reasons. Less than half a dozen re-examinations ...

Lepore starts Aug. 18 at Air Products, which has 23,000 employees spread across 50 countries and ranks 347th in the Fortune ...

Paul Walsh, founder and managing partner of Walsh Barnes, is winding down his practice after 35 years to launch his own ...